Manhattan Hanover Capital Management

home | about | contact

Today's marketplace is characterized by uncertainty and dramatic changes from new technologies, globalization forces, and the economic climate.

Strategies and business models that worked in the past may not be effective in this new competitive landscape. With increasingly rapid change in the market environment, one needs to constantly retool strategic plans in order to adapt to the new environment.

The primary aim of Manhattan Hanover Capital Management is to:

Create a reputation for providing high quality partner opportunities for companies interested in expanding into precision medicine and into artificial intelligence applications in biotech by establishing alliances with top-rated institutions
Provide firms guidance and advice in doing business in protecting and mining large biological datasets, while navigating legal risks

We hope to prepare our clients with partnership that can grow business in non-organic growth pace and gain confidence facing uncertainty as well as being one step ahead in this increasingly competitive, rapidly changing world.